Schramm, W., Buchmann, D., & Hille, H. (2025). Can Pandemic Preparedness Benefit from Health-Economic Modelling? The Case for Nipah Virus. Studies in health technology and informatics, 328, 570–575. https://doi.org/10.3233/SHTI250784

Eble S, Altuntas M, Stecher J, Schramm W., Explorative Untersuchung der medizinischen Versorgungsstruktur der Region Heilbronn-Franken anhand von Personas, in: 68. Jahrestagung der Deutschen Gesellschaft für Medizinische Informatik, Biometrie und Epidemiologie e. V. (GMDS), German Medical Science, Heilbronn, 2023.

Schramm W, Hollenbenders Y, Kurscheidt M. Explorative cost-effectiveness analysis of colorectal cancer recurrence detection with next-generation sequencing liquid biopsy in Spain, France, and Germany. Ther Adv Gastroenterol. 2024 May 10;17:17562848241248246. doi: 10.1177/17562848241248246. PMID: 38737912; PMCID: PMC11088292.

Eble S, Lehmann P, Altuntas M, Stecher J, Schramm W., Explorative Untersuchung der medizinischen Versorgungsstruktur der Region Heilbronn-Franken anhand von Personas, in: 68. Jahrestagung der Deutschen Gesellschaft für Medizinische Informatik, Biometrie und Epidemiologie e. V. (GMDS), German Medical Science, Heilbronn, 2023. DOI: 10.3205/23gmds148. Electronic Supplementary Material to the GMDS 2023 Poster "EXPLORATIVE UNTERSUCHUNG DER MEDIZINISCHEN VERSORGUNGSSTRUKTUR DER REGION HEILBRONN- FRANKEN ANHAND VON PERSONAS": PersonaPosterHHN.PDF.

Diedrich L, Brinkmann M, Dreier M, Rossol S, Schramm W, Krauth C. Is there a place for sigmoidoscopy in colorectal cancer screening? A systematic review and critical appraisal of cost-effectiveness models. PLoS One. 2023 Aug 18;18(8):e0290353. doi: 10.1371/journal.pone.0290353. PMID: 37594967; PMCID: PMC10438011.

Brandl LC, Liebram C, Schramm W, Pobiruchin M. A German Smartphone-Based Self-management Tool for Psoriasis: Community-Driven Development and Evaluation of Quality-of-Life Effects. JMIR Form Res. 2022 Jul 7;6(7):e32593. doi: 10.2196/32593. PMID: 35797109; PMCID: PMC9305401.

Hackenberg B, Büttner M, Schöndorf M, Strieth S, Schramm W, Matthias C, Gouveris H. Quality of Life Assessment for Tonsillar Infections and Their Treatment. Medicina (Kaunas). 2022 Apr 25;58(5):589. doi: 10.3390/medicina58050589. PMID: 35630006; PMCID: PMC9145041.

Diedrich L, Brinkmann M, Dreier M, Schramm W, Krauth C. Additional offer of sigmoidoscopy in colorectal cancer screening in Germany: rationale and protocol of the decision-analytic modelling approach in the SIGMO study. BMJ Open. 2022 Jan 6;12(1):e050698. doi: 10.1136/bmjopen-2021-050698. PMID: 34992106; PMCID: PMC8739067.

Tew M, Willis M, Asseburg C, Bennett H, Brennan A, Feenstra T, Gahn J, Gray A, Heathcote L, Herman WH, Isaman D, Kuo S, Lamotte M, Leal J, McEwan P, Nilsson A, Palmer AJ, Patel R, Pollard D, Ramos M, Sailer F, Schramm W, Shao H, Shi L, Si L, Smolen HJ, Thomas C, Tran-Duy A, Yang C, Ye W, Yu X, Zhang P, Clarke P. Exploring Structural Uncertainty and Impact of Health State Utility Values on Lifetime Outcomes in Diabetes Economic Simulation Models: Findings from the Ninth Mount Hood Diabetes Quality-of-Life Challenge. Med Decis Making. 2021 Dec 15:272989X211065479. doi: 10.1177/0272989X211065479. Epub ahead of print. PMID: 34911405.

Larribère L, Gordejeva J, Kuhnhenn L, Kurscheidt M, Pobiruchin M, Vladimirova D, Martin M, Roser M, Schramm W, Martens UM, Eigenbrod T. Assessment of SARS-CoV-2 Infection among Healthcare Workers of a German COVID-19 Treatment Center. Int J Environ Res Public Health. 2021 Jul 1;18(13):7057. doi: 10.3390/ijerph18137057. PMID: 34281000

Si, L., et al. (2020). "Evaluating the Ability of Economic Models of  Diabetes to Simulate New Cardiovascular Outcomes Trials: A Report on the  Ninth Mount Hood Diabetes Challenge." Value Health 23(9): 1163-1170.  (Schramm W), DOI: 10.1016/j.jval.2020.04.1832, PMID: 32940234

Pobiruchin M, Zowalla R, Kurscheidt M, Schramm W. PrositNG - A Machine Learning Supported Disease Model Generation Software. Stud Health Technol Inform. 2020 Jun 26;272:151-154. doi: 10.3233/SHTI200516. PMID: 32604623.

Heinemann L, Schramm W, Koenig H, Moritz A, Vesper I, Weissmann J, Kulzer B. Benefit of Digital Tools Used for Integrated Personalized Diabetes Management: Results From the PDM-ProValue Study Program. J Diabetes Sci Technol. 2020 Mar;14(2):240-249. doi: 10.1177/1932296819867686. Epub 2019 Aug 5. PMID: 31378074; PMCID: PMC7196877.

Kent S, Becker F, Feenstra T, Tran-Duy A, Schlackow I, Tew M, Zhang P, Ye W, Lizheng S, Herman W, McEwan P, Schramm W, Gray A, Leal J, Lamotte M, Willis M, Palmer AJ, Clarke P. The Challenge of Transparency and Validation in Health Economic Decision Modelling: A View from Mount Hood. Pharmacoeconomics. 2019 Nov;37(11):1305-1312. doi: 10.1007/s40273-019-00825-1. PMID: 31347104; PMCID: PMC6860461.

Schramm  W, Sailer F, Pobiruchin M, Müller A, Weissman J. The Cost-Effectiveness  of the PDM-ProValue Diabetes Management Program in Germany. EASD 2019,  16.-20. September 2019, Barcelona. P820.

Sailer F, Pobiruchin M,  Müller A, Weissmann J, Schramm W. Makrovaskuläre Ereignisse,  Lebensqualität und Mortalität im PDM-ProValue Studienprogramm – eine  vergleichende Langzeitsimulation. Diabetologie und Stoffwechsel 2019;   14(S 01): S13. DOI: 10.1055/s-0039-1688141

Schramm W. Digital Diabetes Self-Management: A Trilateral Serial. J Diabetes Sci Technol. 2018 May;12(3):709-711. doi: 10.1177/1932296818761973. Epub 2018 Mar 7. PMID: 29514509; PMCID: PMC6154233.

Heinemann  L, Daenschel W, Daenschel I, Messinger D, Schramm W, Vesper I,  Weissmann J, Kulzer B: Integrated personalized diabetes management  (iPDM) in patients with insulin-treated T2DM: results of the  PDM-ProValue study program. Poster Presentation at the Congress of the  International Diabetes Federation in Abu Dhabi 2017 DOI:  10.1177/1932296815617487

Sailer F, Hunter R, Schramm W (2017):  Development of a chlamydia infection model for evaluating costs and  outcomes of health interventions. In: GMS Medizinische Informatik,  Biometrie und Epidemiologie 13 (1). DOI: 10.3205/mibe000173

Schramm  W, Rickmann J, Sailer F. Healthy, Sick, Dead – An Education Blueprint to  State Transition Disease Modelling. Studies in Health Technology and  Informatics Health 2017, PMID: 28679929

Seitz P, Fendrich L, Hempe H,  Rickmann J, Christophidis B, Lankes S, Reimchen H, Westers M, Baumann  B, Laha A, Suleder J, Sailer F, Schramm W (2017): Validierung des PROSIT  CHD Type 2 Diabetes Herzinfarktmodells. In: Diabetologie und  Stoffwechsel 12 (S 01), S1-S84. DOI: 10.1055/s-0037-1601719